Tissue Microarrays (TMAs)
High-Throughput Validation: Precision-Engineered TMAs for Accelerated Biomarker Discovery
Creative Bioarray provides high-density Tissue Microarrays (TMAs) designed to maximize research efficiency. By assembling hundreds of miniaturized tissue cores onto a single slide, our TMAs enable simultaneous analysis of protein or gene expression across diverse biospecimens under identical experimental conditions, significantly reducing reagent consumption and technical variability.
Product Features
Extensive Cohort Selection
Our portfolio includes multiple cancer types, normal controls, and disease-specific arrays (e.g., neurodegenerative, inflammatory), covering human, NHP, and common laboratory animal models.
Standardized Core Precision
Each TMA is constructed with precise core diameters (typically 0.6mm - 2.0mm) and optimized spacing, ensuring structural integrity and consistent results across IHC, ISH, and FISH applications.
Application-Specific Designs
We offer specialized array formats, including multi-tumor arrays, progression arrays (from normal to metastatic), and custom-configured layouts tailored to your unique study objectives.
Why Choose Our Tissue Microarrays?
Unmatched Statistical Power
- Simultaneous analysis of large cohorts (up to 400+ cores per slide)
- Elimination of slide-to-slide batch effects
- Preservation of limited and precious donor tissues
- Cost-effective screening of experimental therapeutic targets
- High-resolution digital pathology compatible
Verified Clinical Integrity
- Expert pathologist-validated core selection (H&E guided)
- Comprehensive donor clinical data and pathology reports
- Stringent QC for morphology and biomarker antigenicity
- Ethically sourced specimens with full IRB/EC compliance
- Seamless integration with our IHC staining services
A major differentiator of our Tissue Microarray portfolio is the combination of high-density sampling and deep clinical characterization. We ensure that every core represents the specific pathology of interest, providing researchers with a robust platform for statistically significant biomarker validation.
Request a Quote or Custom Solution
Whether you need a validated tumor progression array or a custom-designed TMA featuring specific donor profiles, Creative Bioarray is committed to delivering high-performance solutions backed by technical expertise and ethical sourcing.
Please tell us your target disease indications, required core density, and clinical criteria, and our specialists will help you identify or design the optimal array for your research.
Filters Clear all filters
Species
- Human (742)
- Monkey (7)
- Mouse (16)
- Rat (13)
Source
- Adipose (1)
- Adrenal Gland (2)
- Appendix (2)
- Bladder (6)
- Blood Vessel (1)
- Bone (8)
- Bone Marrow (3)
- Brain (13)
- Breast (16)
- Cartilage (4)
- Cervix (9)
- Colon (116)
- Endometrium (4)
- Esophagus (73)
- Gallbladder (2)
- Heart (7)
- Intestine (160)
- Kidney (24)
- Large Intestine (2)
- Liver (112)
- Lung (48)
- Multiple Organs (82)
- Muscle (3)
- Ovary (8)
- Pancreas (43)
- Penis (5)
- Prostate (11)
- Rectum (42)
- Skin (33)
- Small Intestine (7)
- Smooth Muscle (2)
- Spleen (8)
- Stomach (83)
- Testis (9)
- Thyroid Gland (5)
- Ureter (1)
- Urethra (1)
- Uterus (13)
Disease
- Cancer (696)
- Crohn's Disease (3)
- Gastric Ulcer (4)
- Gastritis (5)
- Hepatitis (8)
- Liver Cirrhosis (17)
- Normal (443)
- Pancreatitis (4)
- Ulcerative Colitis (2)
Description: Hepatocellular carcinoma tissue microarray, 72 cases/72 cores, containing 63 cases of ...
Description: Liver cancer with liver tissue microarray, containing 18 cases of hepatocellular carcinoma, 1 mixed ...
Description: Hepatocellular carcinoma (HCC) and normal tissue microarray, containing 17 cases of hepatocellular ...
Description: Liver cancer with liver tissue microarray, containing 18 cases of hepatocellular carcinoma, 3 each ...
Description: liver cancer and normal tissue microarray, 70 cases/70 cores, containing 40 cases of hepatocellular ...
Description: Liver intrahepatic cholangiocarcinoma (ICC) tissue microarray, 66 cases/66 cores, containing 66 ...
Description: Hepatocellular carcinoma (HCC) tissue microarray, including TNM, clinical stage and pathology ...
Description: Human liver cancer((stage III) tissue microarray, 34 cases/68 cores, containing 5 cases of ...
Description: Hepatocellular carcinoma tissue microarray with matched normal cancer adjacent tissue, 55 cases/63 ...
Description: Hepatocellular carcinoma tissue microarray, 23 cases/63 cores, containing 20 cases of ...
Description: Hepatocellular carcinoma, 31 cases of tumor and matched normal adjacent tissue
Description: liver cancer tissue microarray,containing 6 cases of hepatic cirrhosis, 17 cases of hepatocellular ...
Description: Multiple liver disease and normal tissue microarray, containing 1 normal liver tissue, 2 ...
Description: Human liver cancer((stage I) with normal tissue microarray, containing 10 hepatocellular carcinoma, ...
Description: Human liver cancer((stage IV) with normal tissue microarray, containing 40 cases of intrahepatic ...
Description: Human liver cancer tissue microarray, containing hepatocellular carcinoma (9 cases), ...
Description: Hepatocellular carcinoma and normal tissue microarray, 23 cases/48 cores, including 12 cases of ...
Description: Multiple liver cancer tissue microarray with 4 normal tissues control from autopsy, with TNM, 24 ...